Trial intelligence / Profile preview

Levetiracetam Follow-up in Pediatric Absence Epilepsy

NCT00545012Phase 2Completed

Sponsor
UCB
Start
May 2000
Primary completion
May 2003
Modality
Small Molecules
01

Overview

A Phase 2 trial of levetiracetam in childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), sponsored by UCB. Started May 2000; status: completed.

02

Drugs

levetiracetam
03

Conditions

childhood absence epilepsy (CAE)juvenile absence epilepsy (JAE)

Beyond the preview

Go deeper on NCT00545012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call